MRK•benzinga•
Merck Says FDA Approves ENFLONSIA For Prevention Of RSV Lower Respiratory Tract Disease In Neonates And Infants Who Are Born During Or Entering First RSV Season
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 9, 2025 by benzinga